• γH2AX DNA Damage Detection: Bridging Mechanism to Applicatio

  2026-05-03

  Explore how precise γH2AX detection redefines translational research in DNA damage, radiotherapy response, and immune modulation—integrating mechanistic insights, leading-edge experimental evidence, and strategic guidance for researchers aiming to accelerate discoveries from bench to bedside.

• Dual Metabolic Reprogramming Boosts Ferroptosis in TNBC Ther

  2026-05-02

  This study introduces a metal-polyphenol nanoplatform that co-targets iron and lipid metabolism, advancing ferroptosis-based therapy for triple-negative breast cancer (TNBC). By unveiling compensatory resistance mechanisms and proposing dual inhibition of DHODH and DGAT1, the research provides a new framework for overcoming therapeutic resistance in aggressive cancers.

• Bismuth Subsalicylate: Strategic Insights for GI Translation

  2026-05-01

  Discover how Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) is reshaping gastrointestinal disorder research through advanced mechanistic understanding and practical translational strategies. This article offers a multidimensional perspective on inflammation pathway modulation, protocol optimization, and competitive positioning, grounded in evidence and actionable recommendations for researchers.

• Quercetin Modulates Glucose and Lipid Metabolism in GDM via

  2026-05-01

  This study identifies quercetin as a regulator of glucose and lipid metabolism in gestational diabetes mellitus (GDM) through modulation of the PCSK9/LDLR axis and activation of the PI3K/AKT/GSK3β pathway. The findings highlight both molecular and functional improvements in glucose uptake and lipid profiles, suggesting translational potential for metabolic disease research.

• Ceapin-A7: Selective ER Stress Blocker for Precision Pathway

  2026-04-30

  Ceapin-A7 stands out as a selective ER stress blocker, enabling researchers to modulate the ATF6α pathway with unmatched specificity. Its robust performance in unfolded protein response studies, along with clear protocol guidance, supports advanced disease modeling and mechanism dissection.

• L-NAME Hydrochloride in Translational CI-AKI and Apoptosis R

  2026-04-30

  Explore the advanced applications of L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) in apoptosis and inflammation signaling modulation, with a unique focus on acute kidney injury models and translational assay design. Discover how APExBIO’s reagent supports cutting-edge vascular and renal research.

• Anti-Fibrotic Effects of 1-Phenyl-2-Pentanol on Hepatic Stel

  2026-04-29

  This study identifies 1-phenyl-2-pentanol, a compound from Moringa oleifera, as a potent inhibitor of hepatic stellate cell activation and fibrogenic signaling in vitro. By elucidating its mechanism—targeting both TGF-β1 and Wnt/β-catenin pathways—the research offers new directions for anti-fibrotic drug development.

• Hexetidine (NSC-17764): Reliable Biofilm & Oral Antimicrobia

  2026-04-29

  This article provides laboratory researchers with scenario-driven guidance on leveraging Hexetidine (NSC-17764), SKU BA1327, as a robust, reproducible solution for biofilm inhibition, oral infection models, and cell-based assays. Integrating literature-backed data, real-world troubleshooting, and vendor selection advice, the piece empowers scientific decision-making and highlights APExBIO’s Hexetidine for sensitive, evidence-driven workflows.

• YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol: Techn

  2026-04-28

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol enables targeted inhibition of hypoxia-inducible factor 1 transcriptional activity and sGC activation in cancer and vascular biology workflows. This reagent is best suited for in vitro and in vivo models requiring precise modulation of HIF-1α or cGMP signaling. Use is restricted to scientific research and not for diagnostic or clinical applications.

• Migratory Interneuron Therapy for Glioblastoma: A Mechanisti

  2026-04-28

  Brosius et al. demonstrate that modified cortical interneuron precursors (MCIPs) can migrate to high-grade glioma and locally deliver bispecific T-cell engagers, prolonging survival in mouse models. This strategy addresses therapeutic delivery challenges in glioblastoma and establishes a novel cellular vector with translational potential.

• GOT1 Inhibition by Ziprasidone Reprograms Redox in Pancreati

  2026-04-27

  Yang et al. (2022) demonstrate that ziprasidone acts as a non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox homeostasis in pancreatic ductal adenocarcinoma (PDAC) cells. Their findings reveal GOT1 as a metabolic vulnerability in PDAC and suggest new experimental directions for targeting tumor redox regulation.

• Notopterol Reprograms Macrophage Metabolism via α7nAChR in S

  2026-04-27

  The referenced study uncovers that Notopterol, a natural compound, alleviates synovitis by promoting anti-inflammatory macrophage polarization through α7 nicotinic acetylcholine receptor (α7nAChR)-dependent metabolic reprogramming. These findings shed light on targeting metabolic pathways in macrophages as a promising strategy for inflammatory arthritis intervention.

• Ibrexafungerp Efficacy Against Fluconazole-Resistant Candida

  2026-04-26

  Wiederhold et al. demonstrate that ibrexafungerp exhibits potent in vitro and in vivo activity against fluconazole-resistant Candida auris, including efficacy even when treatment is delayed. These findings highlight the urgent need for alternative antifungal agents and inform experimental strategies for modeling drug-resistant fungal infections.

• Bismuth Subsalicylate: Practical Guide for GI Disorder Resea

  2026-04-25

  Bismuth Subsalicylate (SKU A8382) addresses key challenges in gastrointestinal disorder research, particularly for studies on inflammation and diarrhea treatment. Its documented insolubility and storage requirements set clear boundaries for experimental design, making it best suited for workflows where solid-phase or suspension formats are acceptable. It should not be used in protocols requiring aqueous, ethanol, or DMSO solubility.

• Leptin (116-130), amide, mouse: Applied Protocols & Optimiza

  2026-04-24

  Leptin (116-130), amide, mouse, a potent adipocyte-derived hormone fragment, enables precise modeling of leptin signaling in metabolic disease research. This article details hands-on protocols, advanced assay use-cases, and troubleshooting strategies for robust experimental outcomes.

14563 records 1/971 page Next 12345 下5页 Last page